Back
Theriva Biologics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
14
TOVX
Theriva Biologics, Inc.
Last Price:
$0.24
Seasonality Move:
13.43%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiTheriva Biologics, Inc. Stock Forecast
-
Is Theriva Biologics, Inc. Stock Undervalued?The current Theriva Biologics, Inc. [TOVX] share price is $0.20. The Score for TOVX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
TOVX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Theriva Biologics, Inc. Stock Go Up Next Year?
Data Unavailable
Theriva Biologics, Inc. Stock Rating
Data Unavailable
Theriva Biologics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
therivabio.com
52-Week Data
52-Week High:
2.08
52-Week Low:
0.20
Prediction Charts
Market Cap:
6.8M
Price in USD:
0.20
Volume:
3.3M
Beta:
-47.69
Technical Analysis
SMA50:
0.34
SMA100:
0.39
SMA200:
0.65
52-Wk Change:
-84.61%
Stock Predictions
-
Is Theriva Biologics, Inc. stock public?Yes, Theriva Biologics, Inc. is a publicly traded company.
-
What is the Theriva Biologics, Inc. stock quote today?The Theriva Biologics, Inc. stock price is 0.20 USD today.
-
How to buy Theriva Biologics, Inc. stock online?You can buy Theriva Biologics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 0.29 | 0.28 | 0.29 | 0.27 |
| Nov-14 | 0.27 | 0.27 | 0.28 | 0.26 |
| Nov-17 | 0.26 | 0.24 | 0.27 | 0.23 |
| Nov-18 | 0.24 | 0.25 | 0.25 | 0.22 |
| Nov-19 | 0.24 | 0.23 | 0.25 | 0.23 |
| Nov-20 | 0.23 | 0.21 | 0.23 | 0.20 |
| Nov-21 | 0.21 | 0.22 | 0.22 | 0.21 |
| Nov-24 | 0.22 | 0.23 | 0.24 | 0.21 |
| Nov-25 | 0.23 | 0.24 | 0.25 | 0.22 |
| Nov-26 | 0.20 | 0.26 | 0.26 | 0.20 |
| Nov-28 | 0.27 | 0.27 | 0.27 | 0.26 |
| Dec-1 | 0.26 | 0.22 | 0.27 | 0.22 |
| Dec-2 | 0.23 | 0.21 | 0.23 | 0.20 |
| Dec-3 | 0.20 | 0.20 | 0.21 | 0.20 |
Theriva Biologics, Inc. Earnings
Data Unavailable
Theriva Biologics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $21.60 per share, and an increase next year of $1.40 per share.
* Theriva Biologics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.